Celldex Therapeutics reported $0 in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Abbvie ABBV:US $ 73474M 3210M
Agenus AGEN:US $ 14.18M 0.63M
Amgen AMGN:US $ 36854M 3545M
Applied Genetic Technologies AGTC:US $ 20.43M 0.16M
Aptinyx Inc APTX:US $ 24.29M 10.14M
Biocept BIOC:US $ 2.24M 0.27M
Bristol Myers Squibb BMY:US $ 44972M 419M
Celldex Therapeutics CLDX:US $ 0M 0M
Cytrx CYTR:US 0 0
Glaxosmithkline GSK:US $ 33328M 9155M
Immunogen IMGN:US $ 0M 0M
Merrimack Pharmaceuticals MACK:US $ 0 0
Nektar Therapeutics NKTR:US $ 0M 0M
Newlink Genetics NLNK:US $ 0M 0M
Northwest Biotherapeutics NWBO:US 28.28M 4.12M
Pfizer PFE:US $ 36301M 2135M
Rigel Pharmaceuticals RIGL:US $ 29.85M 9.93M
Seattle Genetics SGEN:US $ 0M 0M